10.1016/j.jhep.2018.02.012

LAYSUMM

TITLE

The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition

PARAGRAPH

The efficacy of the new direct-acting antivirals is associated with a significant improvement in survival of patients undergoing liver transplantation because of hepatitis C virus-related liver disease.

In addition, it has decreased the number of patients with hepatitis C that need a liver transplant.